A phase I/II study on the anti-CD3/CD7 immunotoxin combination for the treatment of steroid-refractory acute GVHD

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com

ImprintTerms of ServicePrivacy PolicyAccessibility